Intent to Sole Source - CDC Sexually Transmitted Infections Treatment Guidelines published as a Supplement to the Clinical Infectious Diseases Journal (CID)

The Centers for Disease Control and Prevention (CDC), Office of Infectious Diseases, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Division of HIV/AIDS Prevention intends to award a sole source firm fixed price purchase order to The University of Oxford for the publication of a supplement edition of the journal Clinical Infectious Diseases that contains background manuscripts that describe the evidence behind the recommendations in the upcoming 2020 CDC STI Treatment Guidelines document. Oxford University Press is the exclusive publisher for Clinical Infectious Diseases and the sole source for Clinical Infectious Diseases Journal Supplements. This requirement is for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (Simplified Acquisition Procedures and 10 U.S.C. 2304(c)(1). Interested vendors may identify their interest and capability to respond to the requirement. THIS NOTICE OF INTENT IS NOT A REQUEST FOR COMPETITIVE QUOTATIONS; however, all responses received within ten (10) days of the issuance of this notice will be reviewed by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Any response must be emailed to the contract specialist at [email protected] by 5 June 2020 by 12:00 PM EDT.